2025-2031 Global Ciclesonide API Industry Research & Trends Analysis Report- YH Research

日本语 | 中文

Home > Reports >Chemical & Material > 2025-2031 Global Ciclesonide API Industry Research & Trends Analysis Report

2025-2031 Global Ciclesonide API Industry Research & Trends Analysis Report

Publication Date: 2025-10-27
Report Id: 2591475
Industry: Chemical & Material
Report Page: 129
Chart: 129

PDF Download

Publication Date: 2025-10-27
Report Id: 2591475
Industry: Chemical & Material
Report Page: 129
Chart: 129

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Ciclesonide API Definition
1.2 Global Ciclesonide API Market Size and Forecast
1.2.1 By Revenue, Global Ciclesonide API Market Size, 2020-2031
1.2.2 By Sales Volume, Global Ciclesonide API Market Size, 2020-2031
1.2.3 Global Ciclesonide API Price Trend, 2020-2031
1.3 China Ciclesonide API Market Size and Forecast
1.3.1 By Revenue, China Ciclesonide API Market Size, 2020-2031
1.3.2 By Sales Volume, China Ciclesonide API Market Size, 2020-2031
1.3.3 China Ciclesonide API Price Trend, 2020-2031
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Ciclesonide API Share in Global Market, 2020-2031
1.4.2 By Sales Volume, China Ciclesonide API Share in Global Market, 2020-2031
1.4.3 Ciclesonide API Market Size: China VS Global, 2020-2031
1.5 Ciclesonide API Market Dynamics
1.5.1 Ciclesonide API Market Drivers
1.5.2 Ciclesonide API Market Restraints
1.5.3 Ciclesonide API Industry Trends
1.5.4 Ciclesonide API Industry Policy

2 Global Competitive Landscape by Company
2.1 Global Ciclesonide API Revenue by Company, 2020-2025
2.2 Global Ciclesonide API Sales Volume by Company, 2020-2025
2.3 Global Ciclesonide API Price by Company, 2020-2025
2.4 Global Ciclesonide API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Ciclesonide API Concentration Ratio
2.6 Global Ciclesonide API Mergers & Acquisitions, Expansion Plans
2.7 Global Ciclesonide API Manufacturers Product Type

3 China Competitive Landscape by Company
3.1 China Ciclesonide API Revenue by Company, 2020-2025
3.2 China Ciclesonide API Sales Volume by Company, 2020-2025
3.3 China Ciclesonide API Ciclesonide API Participants, Market Position (Tier 1, Tier 2, and Tier 3)
3.4 China Ciclesonide API Market, Sales Percentage of Local Players VS Foreign Players (2020-2025)
3.5 Chinese Local Players, Ciclesonide API Domestic VS Export
3.6 China Market, Ciclesonide API Import & Export
3.6.1 China Market, Ciclesonide API Import & Export, 2020-2031
3.6.2 China Ciclesonide API Import & Export Trends
3.6.3 Main Sources of China Ciclesonide API Import
3.6.4 Export Destination of China Ciclesonide API

4 Ciclesonide API Production by Region
4.1 Global Ciclesonide API Capacity, Production and Capacity Utilization, 2020-2031
4.2 Global Geographic Distribution of Ciclesonide API Manufacturers
4.3 Global Major Manufacturers, Ciclesonide API Capacity Expansion and Future Plans
4.4 Global Ciclesonide API Capacity by Region
4.5 Global Ciclesonide API Production by Region
4.5.1 Global Ciclesonide API Production & Forecast by Region, 2020 VS 2024 VS 2031
4.5.2 Global Ciclesonide API Production by Region, 2020-2025
4.5.3 Global Ciclesonide API Production Market Share & Forecast by Region, 2020-2031

5 Industry Chain Analysis
5.1 Ciclesonide API Industry Chain
5.2 Ciclesonide API Upstream Analysis
5.2.1 Ciclesonide API Core Raw Materials
5.2.2 Main Manufacturers of Ciclesonide API Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Ciclesonide API Production Mode
5.6 Ciclesonide API Procurement Model
5.7 Ciclesonide API Industry Sales Model and Sales Channels
5.7.1 Ciclesonide API Sales Model
5.7.2 Ciclesonide API Typical Distributors

6 Sights by Product Type
6.1 Ciclesonide API Classification
6.1.1 Purity 98%
6.1.2 Purity 99%
6.2 by Type, Global Ciclesonide API Market Size & CAGR, 2020 VS 2024 VS 2031
6.3 by Type, Global Ciclesonide API Revenue, 2020-2031
6.4 by Type, Global Ciclesonide API Sales Volume, 2020-2031
6.5 by Type, Global Ciclesonide API Price, 2020-2031

7 Sights by Application
7.1 Ciclesonide API Segment by Application
7.1.1 Pharmaceutical Industry
7.1.2 Research Organization
7.1.3 Others
7.2 by Application, Global Ciclesonide API Market Size & CAGR, 2020 VS 2024 VS 2031
7.3 by Application, Global Ciclesonide API Revenue, 2020-2031
7.4 by Application, Global Ciclesonide API Sales Volume, 2020-2031
7.5 by Application, Global Ciclesonide API Price, 2020-2031

8 Sales Sights by Region
8.1 By Region, Global Ciclesonide API Market Size, 2020 VS 2024 VS 2031
8.2 By Region, Global Ciclesonide API Revenue, 2020-2031
8.3 By Region, Global Ciclesonide API Sales Volume, 2020-2031
8.4 North America
8.4.1 North America Ciclesonide API Market Size & Forecasts, 2020-2031
8.4.2 By Country, North America Ciclesonide API Market Size Market Share
8.5 Europe
8.5.1 Europe Ciclesonide API Market Size & Forecasts, 2020-2031
8.5.2 By Country, Europe Ciclesonide API Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Ciclesonide API Market Size & Forecasts, 2020-2031
8.6.2 By Country/Region, Asia Pacific Ciclesonide API Market Size Market Share
8.7 South America
8.7.1 South AmericaCiclesonide API Market Size & Forecasts, 2020-2031
8.7.2 By Country, South America Ciclesonide API Market Size Market Share
8.8 Middle East & Africa

9 Sales Sights by Country Level
9.1 By Country, Global Ciclesonide API Market Size & CAGR，2020 VS 2024 VS 2031
9.2 By Country, Global Ciclesonide API Revenue, 2020-2031
9.3 By Country, Global Ciclesonide API Sales Volume, 2020-2031
9.4 United States
9.4.1 United States Ciclesonide API Market Size, 2020-2031
9.4.2 By Company, United States Ciclesonide API Sales Volume Market Share, 2024
9.4.3 by Type, United States Ciclesonide API Market Size, Share, 2024 VS 2031
9.4.4 by Application, United States Ciclesonide API Market Size, Share, 2024 VS 2031
9.5 Europe
9.5.1 Europe Ciclesonide API Market Size, 2020-2031
9.5.2 By Company, Europe Ciclesonide API Sales Volume Market Share, 2024
9.5.3 by Type, Europe Ciclesonide API Market Size, Share, 2024 VS 2031
9.5.4 by Application, Europe Ciclesonide API Market Size, Share, 2024 VS 2031
9.6 China
9.6.1 China Ciclesonide API Market Size, 2020-2031
9.6.2 By Company, China Ciclesonide API Sales Volume Market Share, 2024
9.6.3 by Type, China Ciclesonide API Market Size, Share, 2024 VS 2031
9.6.4 by Application, China Ciclesonide API Market Size, Share, 2024 VS 2031
9.7 Japan
9.7.1 Japan Ciclesonide API Market Size, 2020-2031
9.7.2 By Company, Japan Ciclesonide API Market Share, 2024
9.7.3 by Type, Japan Ciclesonide API Market Size, Share, 2024 VS 2031
9.7.4 by Application, Japan Ciclesonide API Market Size, Share, 2024 VS 2031
9.8 South Korea
9.8.1 South Korea Ciclesonide API Market Size, 2020-2031
9.8.2 By Company, South Korea Ciclesonide API Market Share, 2024
9.8.3 by Type, South Korea Ciclesonide API Market Size, Share, 2024 VS 2031
9.8.4 by Application, South Korea Ciclesonide API Market Size, Share, 2024 VS 2031
9.9 Southeast Asia
9.9.1 Southeast Asia Ciclesonide API Market Size, 2020-2031
9.9.2 By Company, Southeast Asia Ciclesonide API Market Share, 2024
9.9.3 by Type, Southeast Asia Ciclesonide API Market Size, Share, 2024 VS 2031
9.9.4 by Application, Southeast Asia Ciclesonide API Market Size, Share, 2024 VS 2031
9.10 India
9.10.1 India Ciclesonide API Market Size, 2020-2031
9.10.2 By Company, India Ciclesonide API Market Share, 2024
9.10.3 by Type, India Ciclesonide API Market Size, Share, 2024 VS 2031
9.10.4 by Application, India Ciclesonide API Market Size, Share, 2024 VS 2031
9.11 Middle East & Africa
9.11.1 Middle East & Africa Ciclesonide API Market Size, 2020-2031
9.11.2 By Company, Middle East & Africa Ciclesonide API Market Share, 2024
9.11.3 by Type, Middle East & Africa Ciclesonide API Market Size, Share, 2024 VS 2031
9.11.4 by Application, Middle East & Africa Ciclesonide API Market Size, Share, 2024 VS 2031

10 Manufacturers Profile
10.1 Sterling Spa
10.1.1 Sterling Spa Company Information, Head Office, Market Area, and Industry Position
10.1.2 Sterling Spa Ciclesonide API Models, Specifications, and Application
10.1.3 Sterling Spa Ciclesonide API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.1.4 Sterling Spa Company Profile and Main Business
10.1.5 Sterling Spa Recent Developments
10.2 Cipla
10.2.1 Cipla Company Information, Head Office, Market Area, and Industry Position
10.2.2 Cipla Ciclesonide API Models, Specifications, and Application
10.2.3 Cipla Ciclesonide API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.2.4 Cipla Company Profile and Main Business
10.2.5 Cipla Recent Developments
10.3 Pharmaffiliates
10.3.1 Pharmaffiliates Company Information, Head Office, Market Area, and Industry Position
10.3.2 Pharmaffiliates Ciclesonide API Models, Specifications, and Application
10.3.3 Pharmaffiliates Ciclesonide API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.3.4 Pharmaffiliates Company Profile and Main Business
10.3.5 Pharmaffiliates Recent Developments
10.4 Aarti Industries
10.4.1 Aarti Industries Company Information, Head Office, Market Area, and Industry Position
10.4.2 Aarti Industries Ciclesonide API Models, Specifications, and Application
10.4.3 Aarti Industries Ciclesonide API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.4.4 Aarti Industries Company Profile and Main Business
10.4.5 Aarti Industries Recent Developments
10.5 Micronisierungs Kontor Oberrot GMBH
10.5.1 Micronisierungs Kontor Oberrot GMBH Company Information, Head Office, Market Area, and Industry Position
10.5.2 Micronisierungs Kontor Oberrot GMBH Ciclesonide API Models, Specifications, and Application
10.5.3 Micronisierungs Kontor Oberrot GMBH Ciclesonide API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.5.4 Micronisierungs Kontor Oberrot GMBH Company Profile and Main Business
10.5.5 Micronisierungs Kontor Oberrot GMBH Recent Developments
10.6 VAMSI LABS
10.6.1 VAMSI LABS Company Information, Head Office, Market Area, and Industry Position
10.6.2 VAMSI LABS Ciclesonide API Models, Specifications, and Application
10.6.3 VAMSI LABS Ciclesonide API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.6.4 VAMSI LABS Company Profile and Main Business
10.6.5 VAMSI LABS Recent Developments
10.7 Coral Drugs
10.7.1 Coral Drugs Company Information, Head Office, Market Area, and Industry Position
10.7.2 Coral Drugs Ciclesonide API Models, Specifications, and Application
10.7.3 Coral Drugs Ciclesonide API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.7.4 Coral Drugs Company Profile and Main Business
10.7.5 Coral Drugs Recent Developments
10.8 NEWCHEM
10.8.1 NEWCHEM Company Information, Head Office, Market Area, and Industry Position
10.8.2 NEWCHEM Ciclesonide API Models, Specifications, and Application
10.8.3 NEWCHEM Ciclesonide API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.8.4 NEWCHEM Company Profile and Main Business
10.8.5 NEWCHEM Recent Developments
10.9 Beijing Mesochem
10.9.1 Beijing Mesochem Company Information, Head Office, Market Area, and Industry Position
10.9.2 Beijing Mesochem Ciclesonide API Models, Specifications, and Application
10.9.3 Beijing Mesochem Ciclesonide API Sales Volume, Revenue, Price and Gross Margin, 2020-2025
10.9.4 Beijing Mesochem Company Profile and Main Business
10.9.5 Beijing Mesochem Recent Developments

11 Conclusion

12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer

According to YH Research, the global market for Ciclesonide API should grow from US$ million in 2024 to US$ million by 2031, with a CAGR of %for the period of 2025-2031.

The strategic recalibration of 2025 U.S. tariff mechanisms is redefining global economic governance norms. This study deciphers the transmission mechanisms of tariff escalation pathways and global policy responses on corporate investment strategies, regional trade networks, and critical material supply architectures.

Ciclesonide API is a ingrediants that nonhalogenated corticosteroid is converted to its clinically active metabolite, desisobutyryl-ciclesonide, by esterases in the airways.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive study of the global market for Ciclesonide API.
Report Highlights:
(1) Global Ciclesonide API market size (sales volume & revenue), history data from 2020-2025, and forecast data from 2026 to 2031.

(2) Global Ciclesonide API market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(3) China Ciclesonide API market competitive situation, sales, revenue, price, and market share, from 2020 to 2025.

(4) Global Ciclesonide API segment by region (or country), key regions cover the United States, Europe, China, Japan, South Korea, Southeast Asia, and India, etc.

(5) Global Ciclesonide API segment by Type, and by Application, and regional segment by Type, and by Application.

(6) Global major production regions of Ciclesonide API, capacity, production and trends.

(7) Ciclesonide API industry supply chain, upstream, midstream, and downstream analysis.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by Type, covers
Purity 98%
Purity 99%

Market segment by Application, can be divided into
Pharmaceutical Industry
Research Organization
Others

Market segment by players, this report covers
Sterling Spa
Cipla
Pharmaffiliates
Aarti Industries
Micronisierungs Kontor Oberrot GMBH
VAMSI LABS
Coral Drugs
NEWCHEM
Beijing Mesochem